Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gebiotide Anti-P. Acnes is a cosmetic peptide developed and manufactured by **Zhuhai Gene-Biocon** (冀百康). It is marketed as a high-purity raw material for the cosmetic and personal care industry, specifically formulated to address acne vulgaris. The peptide functions by targeting ***Cutibacterium acnes*** (formerly *Propionibacterium acnes*), the commensal bacterium implicated in the pathogenesis of acne. In addition to its antimicrobial positioning, the product is described as a 'repairing peptide,' suggesting secondary benefits in skin barrier restoration or inflammation reduction. As a B2B ingredient, it is intended for incorporation into various topical formulations such as creams, gels, and serums.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gebiotide Anti-P. Acnes.